---
title: How I Treat Older Patients with Ph/BCR-ABL-Negative Acute Lymphoblastic Leukemia
date: '2024-10-11'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39393060/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20241012183834&v=2.18.0.post9+e462414
source: Blood
description: Despite advancements in new treatments, management of older patients
  with acute lymphoblastic leukaemia (ALL) remains an unmet medical need. With increasing
  age, ALL patients have a significantly lower CR rate, higher early mortality and
  relapse rate, and poorer survival compared to younger patients. This is attributed
  to a higher prevalence of adverse prognostic factors among older individuals and
  reduced tolerance to chemotherapy. Progress has been made in tailoring moderately
  ...
disable_comments: true
---
Despite advancements in new treatments, management of older patients with acute lymphoblastic leukaemia (ALL) remains an unmet medical need. With increasing age, ALL patients have a significantly lower CR rate, higher early mortality and relapse rate, and poorer survival compared to younger patients. This is attributed to a higher prevalence of adverse prognostic factors among older individuals and reduced tolerance to chemotherapy. Progress has been made in tailoring moderately ...